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A B S T R A C T
Background: Immunoglobulin G4 (IgG4)-related disease has been suggested to be involved in
cardiovascular disorders such as chronic periaortitis. However, it remains unclear whether
IgG4-related immuno-inﬂammation affects the subclinical stages of aortic remodeling. Here, we
analyzed the relationship between serum IgG4 concentrations and the morphology of the ascending
aorta.
Methods: Serum concentrations of IgG4 were measured in 322 patients who underwent 320-slice
cardiac computed tomography (CT). We assessed the aortic wall area and intravascular area at the
portion between the aortic valve and the bifurcation of the pulmonary artery.
Results: In total, 174 patients (54.0%) were diagnosed to have coronary artery disease (CAD) by cardiac
CT. The intravascular area was signiﬁcantly larger in patients with CAD than in those without (893 mm2
vs. 811 mm2, p = 0.001). The aortic wall area was slightly, but not signiﬁcantly, larger in patients with
CAD than in those without (183 mm2 vs. 176 mm2, p = 0.051). Serum concentrations of IgG4 were
signiﬁcantly higher in patients with an aortic wall area of median or greater size (181 mm2) than in
those with a smaller area (<181 mm2) (32.9 mg/dL vs. 23.1 mg/dL, p = 0.026). In logistic regression
analysis using age, gender, and CAD as covariates, the fourth quartile of IgG4 (55.4 mg/dL) was
signiﬁcantly associated with an aortic wall area of median or greater size with an odds ratio of 2.09.
Conclusions: Serum concentrations of IgG4 were found to be signiﬁcantly associated with the aortic wall
area. These ﬁndings collectively suggest that immuno-inﬂammatory processes may play a role in the
subclinical stages of aortic remodeling.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Immuno-inﬂammatory processes may underlie the remodeling
of arteries of various sizes [1]. In addition, the activation of the
immuno-inﬂammatory system is known to affect the development
and progression of atherosclerosis [2]. Vascular remodeling
represents morphological changes of the vessel wall in response
to various chemokines, inducing reorganization of the vessel
wall structure [3]. This affects not only the vessel diameter but
also the thickness of the arterial wall.* Corresponding author at: Department of Cardiovascular Medicine, University of
Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan.
Tel.: +81 3 3815 5411; fax: +81 3 5800 8806.
E-mail address: asakamoto-tky@umin.ac.jp (A. Sakamoto).
http://dx.doi.org/10.1016/j.jjcc.2014.04.015
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsImmunoglobulin G4 (IgG4), which is a unique antibody in both
structure and function, has been recently reported to play a central
role in certain immune-mediated conditions [4]. Although IgG4 is
the least prevalent component of the four IgG subclasses, it may
lead to overexpression of transforming growth factor b (TGF-b) via
the activation of regulatory T (Treg) cells, resulting in the promotion
of ﬁbrosis. Since Hamano et al. [5] ﬁrst discovered the elevation of
serum IgG4 concentrations and tissue inﬁltration of IgG4-positive
plasma cells in autoimmune pancreatitis, similar clinicopathologic
conditions—now designated IgG4-related disease—have been
increasingly identiﬁed in a wide variety of organs.
Several vascular disorders are, at least in part, considered to
possess such features of IgG4-related disease, including inﬂam-
matory abdominal aortic aneurysm, idiopathic retroperitoneal reserved.
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et al. [9] reported a case of multiple IgG4-related vascular lesions in
which serum concentrations of IgG4 were elevated and numerous
IgG4-positive plasma cells were evident within both an abdominal
aortic aneurysm and tumorous lesions around the coronary artery.
In addition, Kasashima et al. [10] compared IgG4-related thoracic
aortic aneurysm (TAA) with IgG4-unrelated TAA, and concluded
that IgG4-related TAA differed from unrelated TAA by the presence
of ﬁbrous adhesions to the surrounding tissue and histopathologi-
cally thicker aortic walls. Although a relationship between IgG4
and cardiovascular disorders has been frequently reported, it
remains unclear whether IgG4-related immuno-inﬂammation
plays a speciﬁc role in the preclinical stages of vascular remodeling.
The aim of the current study, therefore, was to determine
whether there is an association between serum IgG4 concentra-
tions and the morphology of the aorta among patients who
underwent cardiac computed tomography (CT).
Methods
Subjects
The study was approved by the Ethical Committee of the
University of Tokyo, Tokyo, Japan. Written informed consent
was obtained from all subjects. In total, 322 patients (175 men,
147 women) who gave consent and who underwent 320-slice cardiac
CT between June 2010 and August 2012 were enrolled. The exclusion
criteria were congenital heart disease, and previous surgery of
thoracic aorta including coronary artery bypass graft surgery.
Among the 322 patients enrolled, 174 (54.0%) were diagnosed
to have coronary artery disease (CAD) by cardiac CT. The medians
of plasma concentrations of white blood cell (WBC) and serum
concentrations of high-sensitivity C-reactive protein (hsCRP) were
5900/mL [interquartile range (IR), 4900–6900/mL] and 0.09 mg/dL
(IR, 0.04–0.20 mg/dL), respectively. Body surface area (BSA) was
calculated by the following equation: BSA = 0.007184  (body
weight)0.425  (height)0.725 [11]. Hypertension, dyslipidemia, and
diabetes were diagnosed by reference to medical records. Smoking
status was categorized as never smoker, former smoker, or current
smoker; a patient was judged to be a former smoker when the
period from the time of smoking cessation to cardiac CT was longer
than 1 month.
Laboratory measurements
Serum concentrations of IgG4 were determined with a Behring
Nephelometer II (Siemens Healthcare Diagnostics Products GmbH,
Marburg, Germany) using IgG subclass BS-NIA IgG4 (Medical and
Biological Laboratory Co., Ltd., Nagoya, Japan) as antibodies for
serum samples. Measurements of serum IgG4 concentrations were
performed in duplicate. Plasma concentrations of WBC were
counted by an electric resistance method. Serum concentrations of
hsCRP were measured by an immunoturbidimetric assay. Serum
concentrations of creatinine were measured by an enzymatic
method. The estimated glomerular ﬁltration rate (eGFR) was
calculated by the following equation: eGFR = 194  (serum
creatinine)1.094  (age)0.287 (0.739 if female) [12]. The median
interval between cardiac CT and blood sampling was 15 days
(IR, 7–46 days). During this period, there were no signiﬁcant
changes in medication status, such as antihypertensive drugs or
antidyslipidemic drugs, among the study patients.
CT angiography and image analysis
CT scanning was performed using a 320-slice multidetector
CT scanner (Aquillion ONE, Toshiba, Japan) with prospectiveelectrocardiogram (ECG) gating axial scans. The following scanning
parameters were used: detector conﬁguration, 320 mm  0.5 mm;
rotation time, 350, 375, or 400 ms depending on heart rate; tube
potential, 120 kV; and tube current, 270–550 mA depending on
body weight. Patients received 20–40 mg of oral metoprolol
depending on body weight 2 h before CT scanning if their resting
heart rate was more than 70 beats/min. All patients received
2.5 mg of sublingual isosorbide dinitrate before imaging. Prior to
CT angiography, 3-mm thick slices were acquired during a single
breath hold, covering the volume between the carina and the
diaphragm to measure coronary artery calcium (rotation time,
350 ms; tube potential, 120 kV; tube current, 150 mA). Image
acquisition was synchronized to 40% or 75% of the R–R interval
depending on heart rate. Depending on the body weight, an
average of 51  12 mL of contrast medium (iopamidol 370 mg I/mL,
Bayer Healthcare, Berlin, Germany) was injected for 12.5–14 s. For
patients undergoing CT after February 2012, we added a 30-mL saline
ﬂush after the bolus injection of contrast medium. Scanning was
started with a delay according to the contrast transit time as
determined previously by the bolus tracking method. Image data
were transferred to a workstation for postprocessing (Ziostation,
Ziosoft Inc., Redwood City, CA, USA). We measured minimal lumen
diameter in the stenosis, and vessel lumen diameter immediately
proximal to the stenosis. The diameter of the stenosis was
subsequently calculated by dividing the minimal lumen diameter
by the vessel lumen diameter. CAD was deﬁned to be present when
narrowing of the normal contrast-enhanced lumen to less than 50%
was identiﬁed within any of the 13 segments (segments 1–4, 5–9, and
11–14) in accordance with the coronary classiﬁcation of the American
Heart Association [13]. CT angiographic images were evaluated by
two experienced observers who were blind to the serum IgG4
concentrations of each patient to avoid observer bias.
Measurement of the aortic wall area and intravascular area
The aortic wall area and intravascular area of the ascending
aorta were measured at the midpoint between the aortic valve and
the bifurcation of the pulmonary artery using 0.5-mm slice
contrast enhanced CT images for CT angiography. The cut-off value
of the boundary between the aortic wall and the intravascular
space was determined to be 60% of the average CT value of a region
of interest (ROI), which was set in the center of intravascular space.
Statistical analysis
Data analysis was performed using Dr. SPSS II for Windows
(SPSS Inc., Chicago, IL, USA). Data are expressed as mean  standard
deviation (SD) unless stated otherwise. Differences between the
groups were calculated by Mann–Whitney test, t test, and x2 test.
Correlations between variables were assessed by using Spearman’s
rank correlation coefﬁcient. The area under the receiver operating
characteristic (ROC) curve was calculated to quantify diagnostic
performance. Multivariate analysis was calculated by logistic




The mean age of the 322 patients enrolled was 68.6  9.8 years
(range, 21–90 years). A total of 43 patients (13.4%) had a history of
previous percutaneous coronary interventions. A summary of the
clinical data of patients is provided in Table 1. Calciﬁcation of
the thoracic aorta was observed in 295 patients (ascending aorta,
215 patients; aortic arch, 285 patients; thoracic descending aorta,
Table 1
Baseline characteristics of the study patients.
Variables CAD No-CAD p value
(n = 174) (n = 148)
Male gender, n (%) 110 (63.2) 65 (43.9) 0.001
Age, years 69.6  9.3 67.5  10.2 0.060
Height, cm 161.2  9.5 159.1  9.2 0.047
Weight, kg 63.7  14.6 61.1  13.7 0.112
Body mass index, kg/m2 24.4  4.6 24.0  4.2 0.451
Body surface area, m2 1.67  0.21 1.62  0.20 0.057
Heart rate, bpm 64.5  12.3 63.5  11.7 0.465
eGFR, mL/min/1.73 m2 69.6  20.8 75.6  16.1 0.005
The median of WBC,/mL (IR) 5900 (4900–6900) 5800 (5100–6900) 0.946
The median of hsCRP, mg/dL (IR) 0.09 (0.04–0.19) 0.09 (0.04–0.21) 0.960
Hypertension, n (%) 148 (85.1) 110 (74.3) 0.016
Dyslipidemia, n (%) 146 (83.9) 96 (64.9) <0.001
Diabetes, n (%) 72 (41.4) 39 (26.4) 0.005
Peripheral artery disease, n (%) 12 (6.9) 13 (8.8) 0.528
Abdominal aortic aneurysm, n (%) 2 (1.1) 1 (0.7) 0.659
Thoracic aortic aneurysm, n (%) 3 (1.7) 0 (0.0) 0.109
Antihypertensive medication, n (%) 133 (76.4) 103 (69.6) 0.167
Antidyslipidemic medication, n (%) 103 (59.2) 68 (45.9) 0.018
Antidiabetic medication, n (%) 62 (35.6) 33 (22.3) 0.009
Calciﬁcation of the thoracic aorta, n (%) 165 (94.8) 130 (87.8) 0.024
Smoking status
Former smoking, n (%) 82 (47.1) 43 (29.1)
Current smoking, n (%) 22 (12.6) 14 (9.5)
CTCAG ﬁndings
0 vessel disease, n (%) 0 148 (100)
1 vessel disease, n (%) 78 (44.8) 0
2 vessels disease, n (%) 62 (35.6) 0
3 vessels disease, n (%) 33 (19.0) 0
Values are presented as mean  standard deviation unless stated otherwise.
CAD, coronary artery disease; eGFR, estimated glomerular ﬁltration rate; WBC, white blood cell; hsCRP, high-sensitivity C-reactive protein; IR, interquartile range; CTCAG,
computed tomography coronary angiography.
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higher in patients with CAD than in those without. A representative
case of measurements of the aortic wall area and intravascular
area is shown in Fig. 1. The median of the intravascular area was
signiﬁcantly larger in patients with CAD [893 mm2 (IR, 755–1042)]
than in those without [811 mm2 (IR, 677–985), p = 0.001]. The
median of the aortic wall area was slightly, but not signiﬁcantly,
larger in patients with CAD [183 mm2 (IR, 168–199)] than in those
without [176 mm2 (IR, 153–198), p = 0.051] (Fig. 2). Both the
intravascular area and aortic wall area were signiﬁcantly greater in
patients with aortic calciﬁcation than in those without [intravascular
area, 879 mm2 (IR, 725–1025) vs. 725 mm2 (IR, 658–812), p = 0.002;Fig. 1. A representative case of measurements of the aortic wall area and intravascular a
between the aortic valve and the bifurcation of the pulmonary artery. (B) The colorized ve
value or greater. The cut-off value was deﬁned as 60% of the average CT value of a reg
represents a CT density between 1 and this cut-off CT value. In this case, the cut-off C
Hounsﬁeld units. (C) The area of the ascending aorta was manually traced on the boundaraortic wall area, 182 mm2 (IR, 164–200) vs. 169 mm2 (IR, 153–191),
p = 0.010]. The relationship between the body mass index (BMI), BSA,
eGFR, intravascular area, and aortic wall area was assessed by
Spearman’s rank correlation (Table 2). Both the intravascular area
and aortic wall area were signiﬁcantly associated with BMI and BSA,
and both had a signiﬁcant negative association with eGFR.
Association between serum IgG4 concentration and aortic morphology
In the current study population, the median of serum IgG4
concentration was 29.2 mg/dL (IR, 14.5–54.6). Spearman’s
rank correlation coefﬁcient for the relationship of serum IgG4rea. (A) The contrast-enhanced computed tomography (CT) image at the midpoint
rsion of (A) according to CT density. The yellow area shows a CT density of the cut-off
ion of interest, which was set in the center of intravascular space. The green area
T value of the boundary between the aortic wall and the intravascular space 352










































Fig. 2. Box-and-whisker plot of (A) the aortic wall area and (B) intravascular area according to the presence or absence of coronary artery disease (CAD). Statistical outliers are
shown by black circles and extrema are shown by white circles. The whiskers represent the lowest value still within 1.5 interquartile ranges of the lower quartile and the
highest value still within 1.5 interquartile ranges of the upper quartile. The bottom and top of boxes represent the ﬁrst and third quartiles, respectively. The band inside the


































Fig. 3. Box-and-whisker plot of serum immunoglobulin G4 (IgG4) concentrations (A) according to an aortic wall area of 181 mm2 (median) or <181 mm2 or (B) according to
an intravascular area of 866 mm2 (median) or <866 mm2. Statistical outliers are shown by black circles and extrema are shown by white circles. The whiskers represent the
lowest value still within 1.5 interquartile ranges of the lower quartile and the highest value still within 1.5 interquartile ranges of the upper quartile. The bottom and top of
boxes represent the ﬁrst and third quartiles, respectively. The band inside the box represents the median values. The p values were calculated by the Mann–Whitney U test.
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0.001 (p = 0.989) and 0.096 (p = 0.084), respectively. Serum IgG4
concentrations were signiﬁcantly higher in patients with an aortic
wall area of median or greater size (181 mm2) than in those with
a smaller area (<181 mm2) [32.9 mg/dL (IR, 15.1–72.2) vs.
23.1 mg/dL (IR, 13.5–46.4), p = 0.026]. On the other hand, serumTable 2
Spearman’s rank correlation coefﬁcient.






p value <0.001 –
eGFR
r 0.093 0.064 –
p value 0.096 0.249 –
Intravascular area
r 0.115 0.214 0.244 –
p value 0.039 <0.001 <0.001 –
Aortic wall area
r 0.145 0.224 0.275 0.554 –
p value 0.009 <0.001 <0.001 <0.001 –
BMI, body mass index; BSA, body surface area; eGFR, estimated glomerular
ﬁltration rate.IgG4 concentrations did not signiﬁcantly differ between patients
with an intravascular area of median or greater size (866 mm2)
and those with a smaller size (<866 mm2) in the current study
sample [30.2 mg/dL (IR, 13.4–60.9) vs. 27.5 mg/dL (IR, 15.3–51.3),
p = 0.954] (Fig. 3). The area under the ROC curve of the serum IgG4
concentrations for an aortic wall area of median or greater size and
for an intravascular area of median or greater size was 0.57
(standard error, 0.032, p = 0.026) and 0.50 (standard error, 0.032,
p = 0.954), respectively.
Multivariate analysis
In logistic regression analysis using age, gender, and CAD as
covariates, the fourth quartile of IgG4 (55.4 mg/dL) was
signiﬁcantly associated with an aortic wall area of median or
greater size (181 mm2) with an odds ratio of 2.09. When the
peripheral artery disease, BMI, BSA, eGFR, hypertension, and the
calciﬁcation of the thoracic aorta were added as independent
variables, the fourth quartile of IgG4 remained signiﬁcantly
associated with an aortic wall area of median or greater size
(Table 3). Furthermore, this relationship remained to be statisti-
cally signiﬁcant with an odds ratio of 2.07 (95% conﬁdence
interval [CI], 1.08–3.97), even after patients with aortic aneurysm
and those with serum hsCRP concentrations of 2.00 mg/dL or
plasma WBC concentrations of 10,000/mL were both excluded
from the analysis. In age- and gender-adjusted logistic regression
Table 3
Multivariate logistic regression analysis.
Dependent variable
Aortic wall area 181 mm2 Intravascular area 866 mm2
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Model 1
Age (per 1 SD) 2.44 (1.82–3.28) <0.001 1.65 (1.29–2.12) <0.001
Gender 2.98 (1.81–4.91) <0.001 2.24 (1.40–3.59) 0.001
IgG4-Q1_3 1.00 Reference – 1.00 Reference –
IgG4-Q4 2.10 (1.17–3.79) 0.013 1.10 (0.64–1.89) 0.727
Model 2
Age (per 1 SD) 2.43 (1.80–3.27) <0.001 1.62 (1.26–2.08) <0.001
Gender 2.92 (1.76–4.86) <0.001 2.10 (1.30–3.38) 0.002
Coronary artery disease 1.11 (0.67–1.82) 0.690 1.50 (0.94–2.39) 0.091
IgG4-Q1_3 1.00 Reference – 1.00 Reference –
IgG4-Q4 2.09 (1.16–3.77) 0.014 1.09 (0.63–1.86) 0.767
Model 3
Age (per 1 SD) 3.22 (2.15–4.84) 0.000 1.64 (1.17–2.30) 0.017
Gender 1.39 (0.65–2.95) 0.394 1.17 (0.57–2.40) 0.008
Coronary artery disease 1.09 (0.65–1.84) 0.737 1.35 (0.83–2.20) 0.233
Peripheral artery disease 0.76 (0.28–2.05) 0.584 0.78 (0.30–2.01) 0.543
Body mass index (per 1 SD) 0.85 (0.56–1.30) 0.462 0.96 (0.64–1.44) 0.058
Body surface area (per 1 SD) 2.04 (1.16–3.59) 0.014 1.67 (0.98–2.83) 0.062
eGFR (per 1 SD) 0.89 (0.68–1.16) 0.401 0.79 (0.61–1.02) 0.062
Hypertension 0.88 (0.46–1.72) 0.718 1.19 (0.64–2.21) 0.557
Aortic calciﬁcation 0.71 (0.24–2.05) 0.526 2.80 (0.91–8.63) 0.081
IgG4-Q1_3 1.00 Reference – 1.00 Reference –
IgG4-Q4 1.86 (1.02–3.42) 0.044 0.91 (0.52–1.60) 0.752
Aortic wall area of median or greater size (181 mm2) and intravascular area of median or greater size (866 mm2) were used as a dependent variable.
Model 1: Independent variables included age (per 1 SD), gender, and quartiles of IgG4.
Model 2: Independent variables included those in Model 1 + coronary artery disease.
Model 3: Independent variables included those in Model 2 + peripheral artery disease, body mass index (per 1 SD), body surface area (per 1 SD), eGFR (per 1 SD),
hypertension, and calciﬁcation of the thoracic aorta.
eGFR, estimated glomerular ﬁltration rate; SD, standard deviation.
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each IgG4 quartile for an aortic wall area of median or greater
size was 1.00 (reference), 0.78 (95% CI, 0.39–1.56), 0.95 (95% CI,
0.48–1.88), and 1.91 (95% CI, 0.93–3.90), respectively, compared
with the lowest corresponding quartile.
Discussion
In the current study, we found that, among patients who
underwent cardiac CT, serum concentrations of IgG4 were
signiﬁcantly higher in those with an aortic wall area of median
or greater size than in those with a smaller area. In addition, in our
current study sample, serum IgG4 concentration did not have an
apparent relationship with the intravascular area, although the
aortic wall area was signiﬁcantly associated with the intravascular
area. The current ﬁndings collectively suggest that IgG4-related
immuno-inﬂammation may play a role in the subclinical stages of
aortic wall remodeling.
As compared with other IgG subclasses, IgG4 has amino acid
differences within the second constant domain, which lead to
weak or negligible binding to both C1q and Fcg receptors;
therefore, it has been traditionally considered that IgG4 cannot
activate the classical complement pathway effectively and that it
may play only a limited role in immune activation [14,15]. The
production of IgG4 is mainly regulated by type 2 helper T (Th2)
cells. Th2 cytokines such as interleukin-4 and interleukin-13
enhance the production of IgG4 as well as IgE. Furthermore, Treg
cells have been found to be activated in IgG4-related disease in
notable contrast to classic autoimmune conditions, where the
function of Treg cells is impaired [4].
Many medical disorders affecting various organs, such as the
lung, kidney, thyroid, and lymph nodes, were originally recognized
as conditions conﬁned to that single organ, but have been recently
revealed to be a component of IgG4-related disease [16–19].Uchida et al. [20] reported that the total number of patients with
IgG4-related disease in Japan in 2009 was thought to be
approximately 8000, suggesting that IgG4-related disease is not
a rare condition. Moreover, several previous reports indicate that
IgG4-related disease may involve the cardiovascular system in
addition to other organs. For example, Ito et al. [6] reported a
patient who had both inﬂammatory abdominal aortic aneurysm
and retroperitoneal ﬁbrosis with autoimmune pancreatitis. In their
case, the aortic wall was thickened with marked ﬁbrosis and, on
immunohistochemical analysis, many IgG4-positive plasma cells
were observed in the adventitia. Furthermore, Kasashima et al. [21]
reported that 4 of 10 patients with inﬂammatory abdominal aortic
aneurysm had numerous inﬁltrating IgG4-positive plasma cells
and high serum IgG4 concentrations. Moreover, IgG4-positive
plasma cells have been reported to mostly inﬁltrate the adventitia
[22]. It was also found that the adventitia was signiﬁcantly thicker
in IgG4-related inﬂammatory abdominal aortic aneurysm than in
non-IgG4-related inﬂammatory abdominal aortic aneurysm [23].
IgG4-related perivascular immuno-inﬂammation can be ob-
served not only in large vessels such as the aorta, but also in
smaller vessels such as coronary arteries [24]. For example,
Debonnaire et al. [25] reported a case of giant coronary artery
aneurysm that was diagnosed as IgG4-related disease by kidney
biopsy. In addition, Kusumoto et al. [26] reported a patient
with mass lesions surrounding both the coronary artery and
abdominal aorta that were associated with IgG4-related disease
as diagnosed by a needle biopsy. Furthermore, we have recently
shown that serum concentrations of IgG4 were signiﬁcantly
higher in patients with CAD than in those without [27]. Our
previous report not only raised the possibility that IgG4-related
immuno-inﬂammation may be associated with stenosing lesions
of the cardiovascular system and dilated lesions or perivasculitis,
but also indicated that IgG4-related immuno-inﬂammation may
affect the cardiovascular system even among populations without
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immuno-inﬂammation may generally affect cardiovascular
disorders has also been suggested in cases of abdominal aortic
aneurysm. It should be noted that periaortic inﬁltration of
IgG4-positive plasma cells has been observed in cases of athero-
sclerotic abdominal aortic aneurysm (which is rarely recognized as a
component of IgG4-related disease in comparison to inﬂammatory
abdominal aortic aneurysm), although the number of inﬁltrating
IgG4-positive plasma cells is, of course, greater in cases of
inﬂammatory abdominal aortic aneurysm than in cases of
atherosclerotic abdominal aortic aneurysm [28]. Taking these
observations together, we can formulate the hypothesis that
IgG4-related immuno-inﬂammation may be associated not with a
single speciﬁc limited condition but with an inﬂammatory condition
in general.
Cases of inﬂammatory abdominal aortic aneurysm and
idiopathic retroperitoneal ﬁbrosis, some of which are known to
be IgG4-related, can be included under the umbrella term ‘‘chronic
periaortitis’’ [29,30]. Chronic periaortitis is characterized by
advanced aortic atherosclerosis, medial thinning, and pronounced
adventitial and periaortic inﬂammation and ﬁbrosis [31]. Although
the pathogenesis of chronic periaortitis remains unclear, several
potential pathogenetic mechanisms have been suggested. For
example, Mitchinson and Parums proposed that chronic periaor-
titis is a consequence of a local inﬂammatory reaction. Athero-
sclerotic plaque macrophages elaborate antigens, such as oxidized
low-density lipoproteins (LDLs) and ceroid, and, when the aortic
media is thinned or breached, these antigens are presented by
plaque macrophages to immunocompetent cells including B
lymphocytes and T lymphocytes. This action initiates a self-
perpetuating inﬂammatory response, leading to inﬂammation of
the aortic wall mainly concentrated in the media and adventitia
[31,32]. It has been reported that cytokines such as interferon-g,
interleukin-1a, interleukin-2, and interleukin-4 are observed in
sections of abdominal aortic adventitia associated with chronic
periaortitis, but not in those of the normal aortic wall, strengthen-
ing the hypothesis that chronic periaortitis is associated with
active chronic inﬂammation of the adventitia [33]. In addition,
as previously mentioned, interleukin-4 is a Th2 cytokine and
enhances the production of IgG4, which may explain why chronic
periaortitis is, in part, included in IgG4-related disease.
By contrast, it has been recently suggested that chronic
periaortitis is a manifestation of a systemic autoimmune disease
rather than an exaggerated local reaction to atherosclerosis [34].
Vasculitis of the aortic vasa vasorum and periaortic retroperitoneal
vessels may lead to the development of chronic periaortitis by
promoting atherosclerosis, medial thinning, and aneurysm forma-
tion. Furthermore, its extension into the adjacent retroperitoneum
may cause a ﬁbroinﬂammatory reaction, which is typical of chronic
periaortitis [35]. Adventitial and periadventitial inﬂammation are
observed in cases of both idiopathic retroperitoneal ﬁbrosis and
inﬂammatory abdominal aortic aneurysm, but dilated aorta is seen
only in inﬂammatory abdominal aortic aneurysm, and not in
idiopathic retroperitoneal ﬁbrosis [29]. Our present results,
together with these previous observations, support the hypothesis
that IgG4-related immuno-inﬂammation may affect aortic
wall remodeling even among populations without apparent
IgG4-related disease, although we did not evaluate local expres-
sion of IgG4 and we assessed the aortic wall area, not the aortic
adventitial area, in the current study. The relationship between
IgG4 and the aortic adventitial area should be examined in
future studies that incorporate an assessment of histological
images of the aorta.
Our study has several potential limitations. First, we enrolled
relatively high-risk patients who underwent cardiac CT. The
analysis should be repeated in the general population—forexample, among individuals undergoing a general health screen-
ing. Second, owing to the cross-sectional nature of the study, we
cannot draw conclusions on the causal and resultant association
between serum IgG4 concentration and the aortic wall area.
A longitudinal follow-up of the patients should be conducted to
solve this problem. Third, because the sample size was relatively
small in the current study, it cannot be concluded deﬁnitively that
serum IgG4 concentrations are not associated with the intravas-
cular area. A larger sample size should be assessed in a future
study. Fourth, to assess the role of IgG4-related immuno-
inﬂammation in aortic remodeling further, it will be necessary
to assess the presence of IgG4-positive plasma cells in the
adventitia of aorta by an immunohistochemical method because
the degree of IgG4-positive staining does not necessarily correlate
with elevated serum IgG4 [36].
In conclusion, by analyzing the data from patients who
underwent cardiac CT, we have shown that serum concentrations
of IgG4 were, at least in part, independently associated with the
aortic wall area. Our ﬁndings in the current study suggest that
IgG4-related immuno-inﬂammation may underlie the develop-
ment and/or progression of the subclinical stages of aortic wall
remodeling.
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